Clinical Management of Major Postoperative Bleeding After Bariatric Surgery

• Published in: Obesity surgery Vol. 34; no. 3; pp. 751 - 759
• Main Authors: Kollmann, Lars, Gruber, Maximilian, Lock, Johan F., Germer, Christoph-Thomas, Seyfried, Florian
• Format: Journal Article
• Language: English
• Published: New York Springer US 01.03.2024; Springer Nature B.V
• Subjects: Bariatric Surgery - adverse effects; Diabetes Mellitus, Type 2 - complications; Diabetes Mellitus, Type 2 - surgery; Endoscopy; Gastrectomy - adverse effects; Gastric Bypass - adverse effects; Gastrointestinal surgery; Humans; Medicine; Medicine & Public Health; Obesity, Morbid - surgery; Original Contributions; Postoperative Complications - etiology; Postoperative Hemorrhage - epidemiology; Postoperative Hemorrhage - etiology; Postoperative Hemorrhage - therapy; Retrospective Studies; Surgery; Treatment Outcome; Postoperative bleeding; Bariatric surgery; Gastric bypass; Sleeve gastrectomy
• ISSN: 0960-8923; 1708-0428
• DOI: 10.1007/s11695-023-07040-0

Introduction Major postoperative bleeding (mPOB) is the most common complication after bariatric surgery. Its intesity varies from self-limiting to life-threatening situations. Comprehensive decision-making and treatment strategies are mandatory but not established yet. Methods We retrospectively analyzied our prospectively collected database of our bariatric patients during 2012–2022. The primary study endpoint was major postoperative bleeding (mPOB) defined as hemoglobin drop > 2 g/dl or clinically relevant bleeding requiring intervention (transfusion, endoscopy or surgery). Secondary endpoints were overall complications according to Clavien-Dindo-Classification and comprehensive-complication-index (CCI). Results We identified 1017 patients, of whom 667 underwent gastric bypass (GB) and 350 sleeve gastrectomy (SG). Major postoperative bleeding occured in 39 patients (total 3.8%; 5.1% after GB and 2.3% after SG). Patients with mPOB were more often diagnosed with type 2 diabetes ( p  = 0.039), chronic kidney failure ( p  = 0.013) or received antiplatelet drug treatment ( p  = 0.003). The interval from detection to intervention within 24 h was 92.1% (35/39). Blood transfusions were necessary in 20/39 cases (total 51.3%; 45.2% after GB and 75% after SG; p  = 0.046). Luminal bleeding only occured after GB (19/31; 61.3%), while all mPOB after SG were intraabdominal ( p  = 0.002). Reoperations were performed in 21/39 (total 53.8%; 48.4% after GB and 75% after SG; p  = 0.067). CCI in patients with mPOB was 34.7 overall, with 31.2 after GB and 47.9 after SG ( p  = 0.005). Conclusion The clinical appearance of mPOB depends on the type of surgery with severe bleedings after SG. We suggest a surgery first approach for mPOB after SG and an endoscopy first approach after GB. Graphical Abstract